|
|
|
|
Document Preview For Immediate Release |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
For Immediate Release |
|||
|
Entities: |
Endo Pharmaceuticals Holdings Inc.; Georgetown University; New York University; Skadden, Arps, Slate, Meagher & Flom LLP |
|||
|
Date: |
2000 |
|||
|
Size: |
Preview shows 3KB of 12KB total |
|||
|
Price: |
$33 |
|||
|
ID: |
#302059 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
FOR IMMEDIATE RELEASE
Contact: Robert Siegfried/Jeremy Fielding
Kekst and Company
212-521-4800
ENDO PHARMACEUTICALS ANNOUNCES APPOINTMENT OF NEW DIRECTOR
AND HIRING OF TWO NEW EXECUTIVE OFFICERS AND
TWO NEW EXECUTIVES
JOIN GROWING MANAGEMENT TEAM AT LEADING PAIN-MANAGEMENT
PHARMACEUTICAL COMPANY
Chadds Ford, PA, September 27, 2000 - Endo Pharmaceuticals
Holdings Inc. (NASDAQ: ENDP and ENDPW), a fully integrated pharmaceuticals
company with market leadership in pain management, today announced the
appointment of a new director as well as the hiring of two new executive
officers and two new executives further building the expertise of its
senior management team. Joseph T. O'Donnell, Jr. has been appointed by the
company's Board of Directors to serve on the Board, taking the place of
David Fyfe, who resigned in order to pursue other opportunities. Joining
the executive management team are Peter A. Lankau as Senior Vice President,
U.S. Business and Caroline E. Berry as Senior Vice President, General
Counsel and Secretary. In addition, Bradley S. Galer, MD joined Endo as
Vice President, Scientific Affairs and James H. Conover, Ph.D. joined as
Vice President, Regulatory Affairs.
Carol A. Ammon, President and Chief Executive Officer, said "The
company is very pleased to have Mr. O'Donnell join the Board of Directors.
His experience at Metzler Corporation as well as his long history at
Bankers Trust will add a welcome perspective to the Board. We thank Mr.
Fyfe for his contributions to the Endo Board and wish him well in his new
endeavors. In addition, we are very excited to welcome Mr. Lankau, Ms.
Berry, Dr. Galer and Mr. Conover to the Endo team. As a group, these
talented and enthusiastic individuals will make an immediate contribution
in helping Endo achieve even greater success in the growing pain-management
market. Individually, Ms. Berry provided us with valuable counsel during
our merger with Algos, and we are thrilled that she accepted our offer to
become our in-house counsel. A leader in the development of the discipline
of pain management, Dr. Galer brings unique perspective to Endo and is
extremely well equipped to serve as our chief medical officer. For over
twenty-five years, Mr. Lankau has developed his expertise in the sales and
marketing of pharmaceuticals, and Endo will benefit greatly from his
business acumen and strategic vision. Finally, Mr. Conover has a wealth of
experience in regulatory issues, and is ideally-suited to take charge of
the process of regulatory approvals for Endo's innovative pain-management
products."
JOSEPH T. O'DONNELL, JR.
Joseph T. O'Donnell, Jr. is currently the President of Metzler
|
End of Preview |
Home Intelligence Services Subscriptions News About Us